Oncogene alterations in primary, recurrent, and metastatic human bone tumors.
about
Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate TherapiesMicroRNAs and Potential Targets in Osteosarcoma: ReviewOsteosarcoma Overview.Biomarkers in Osteosarcoma.The genetics of osteosarcoma.Defective osteogenic differentiation in the development of osteosarcoma.MicroRNA-29b-1 impairs in vitro cell proliferation, self‑renewal and chemoresistance of human osteosarcoma 3AB-OS cancer stem cells.MYC suppresses cancer metastasis by direct transcriptional silencing of αv and β3 integrin subunitsExpression of Vascular Endothelial Growth Factor correlates with the advance of clinical osteosarcomaThe Current and Future Therapies for Human Osteosarcoma.Osteosarcoma development and stem cell differentiationDominant negative LRP5 decreases tumorigenicity and metastasis of osteosarcoma in an animal model.alpha-CaMKII controls the growth of human osteosarcoma by regulating cell cycle progression.Molecular basis of differentiation therapy for soft tissue sarcomas.Canine osteosarcoma cells exhibit resistance to aurora kinase inhibitors.LPA-induced suppression of periostin in human osteosarcoma cells is mediated by the LPA(1)/Egr-1 axis.High VEGF with rapid growth and early metastasis in a mouse osteosarcoma model.Common mechanism of pathogenesis in various types of metastatic osteosarcoma.A streamlined workflow for single-cells genome-wide copy-number profiling by low-pass sequencing of LM-PCR whole-genome amplification products.
P2860
Q26782646-1A4CD020-0E3A-4C01-96E2-E9FC5386F7E4Q26784033-4F5600F5-E37A-4D1E-A0FE-741CC7D86C43Q33725511-D25F2A9D-5D21-47F5-B2D8-98A4E22AEE32Q33929072-402A3044-342F-4CEE-A00D-DDE2D83D43C1Q34639086-2611E8DF-F82F-47D1-9C3E-A6053D2EC667Q34700590-71706EA1-7057-4CD5-BE5D-D9048F4A8AE2Q35609245-EEDCE643-7578-4D7C-B41C-4E125849746AQ36004007-1BB82A15-5DAD-4954-9120-3CAE8E59D165Q36341865-9B1A88A1-C688-4E64-8014-16781212B238Q36514299-6F819079-D29A-4396-9F32-32DB5A701C91Q36803600-C4F519D1-D63B-42ED-B525-B50B6C4F007BQ36803627-166AC109-7546-495D-904B-D5648A66ECCCQ37319003-B594F5A6-1F2B-44CE-9A0C-51417A0BDFE0Q38588243-9633F3D5-0334-420E-8945-D436EE7DBDC6Q39194457-1CA3049C-D08A-47F4-82E8-04566FA34258Q39338040-19B0B263-E682-4350-BB8C-35361EF99AAEQ41917605-A42BF8FC-FC60-45DE-A173-37F4EF4579FDQ47130991-5B09BF3C-1476-474F-9D42-931AA35C4DDDQ52370966-0130D362-BB84-4726-9A86-083B326FBD88
P2860
Oncogene alterations in primary, recurrent, and metastatic human bone tumors.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Oncogene alterations in primary, recurrent, and metastatic human bone tumors.
@en
type
label
Oncogene alterations in primary, recurrent, and metastatic human bone tumors.
@en
prefLabel
Oncogene alterations in primary, recurrent, and metastatic human bone tumors.
@en
P2093
P1476
Oncogene alterations in primary, recurrent, and metastatic human bone tumors.
@en
P2093
Freidlin B
Pompetti F
P356
10.1002/(SICI)1097-4644(199610)63:1<37::AID-JCB3>3.3.CO;2-Z
P50
P577
1996-10-01T00:00:00Z